Lilly, Merck, And Pfizer Announce the Formation of the Asian Cancer Research Group, Inc.
Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
SUBSCRIBE